Yesterday it finally happened – the oral argument in Wyeth v. Levine at the Supreme Court – where at issue is if drug-makers are shielded from failure to warn lawsuits when the FDA has approved the labeling for a drug. Reports indicate that the justices appeared to be closely split, with some searching for a narrow way to decide the issue. To read more, see an article by David Savage in the Los Angeles Times. Of course, we can only speculate about the result until the decision is handed down.